Frost & Sullivan awards AKI Product Leadership Award to BioPortoRead more
American Association for Clinical Chemistry (AACC) push for AKI biomarkers including NGAL in new cover storyRead more
We are happy to announce that The NGAL Test™ application notes are now available for the Siemens Dimension Vista® Integrated Chemistry System's nephelometric chanel and the turbidemetric analyzer from Beckman Coulter UniCel® DxC 800 Synchron® Clinical System. Both application notes are designed for urine samples only.Read more
Ever since NGAL as a diagnostic biomarker was linked to AKI, NGAL has been given a central role in many international AKI initiatives.
The connection between NGAL and AKI diagnostics has led to a wealth of forums and informational resources strengthening the focus on the subject.
To provide an overview and easy access to all these free available resources, we have collected the most recent high impact links and posted them on www.NGAL.comRead more
We are happy to announce that The NGAL Test™ is now available
for the Siemens ADVIA 1800 analyzer.
Together with Roche and Abbott, Siemens is a leading supplier of instruments for laboratory diagnostics worldwide and has a large number of ADVIA systems placed in first-class laboratories. This means that considerably more hospitals and testing sites can now start working with BioPorto's automated NGAL test.
Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.
To download as pdf please click hereRead more
Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising biomarker for acute kidney injury (AKI). The ultimate goal is for NGAL to enable clinicians to intervene as early as possible and to change the prognosis of AKI.
To download as pdf please click hereRead more
BioPorto Diagnostics announces the presentation of a new scientific study that includes data obtained with The NGAL Test - the company's forthcoming diagnostic test for acute kidney injury soon to be introduced for open clinical chemistry analyzers.Read more
The Society of Critical Care Medicine (SCCM)annual congress is the largest gathering of diverse and creative thought leaders from all over the world.Read more
The American Society of Nephrology's Renal Week is the world's most significant nephrology meeting devoted to the latest advances in research, clinical care and education in kidney diseases.Read more
As the world's largest medical trade fair, MEDICA once again offers a comprehensive overview of a wide variety of innovations in the world of healthcare.Read more
BioPorto Diagnostics is exhibiting at the 23rd Annual Congress of the European Society of Intensive Care Medicine. Visit us at booth no. 52.Read more
The AACC/Clinical Laboratory Expo is the leading event for clinical chemistry, clinical laboratory science and laboratory medicine products and services.Read more
BioPorto Diagnostics will be exhibiting at the XII International Congress of Toxicology, IUTOX 2010, and presenting the latest developments in its Pharma NGAL product line.Read more
The European Renal Association - European Dialysis and Transplant Association(ERA-EDTA) and the German Society of Nephrology (Deutsche Gesellschaft für Nephrologie, DGfN) join forces to organize the XLVII ERA-EDTA Congress in Munich.Read more
BioPorto Diagnostics joins forces with its Korean distributor, Dong-In Biotech, to promote BioPorto's NGAL products at the 12th Asian Pacific Congress of Nephrology (APCN 2010).Read more
BioPorto Diagnostics will participate at the 8th World Congress on Trauma, Shock, Inflammation and Sepsis - TSIS 2010Read more
BioPorto Diagnostics joins forces with its partner in the US and Canadian markets, ALPCO Diagnostics, in promoting the animal and human NGAL product line at ToxExpo.Read more
BioPorto Diagnostics will be exhibiting at the upcoming International Critical Care Congress of the Indian Society of Critical Care Medicine (ISCCM).Read more
The Society of Critical Care Medicine (SCCM) annual congress is the largest gathering of diverse and creative thought leaders from all over the world.Read more
Bioporto Diagnostics is exhibiting at the 24th Annual Congress of the European Society of Intensive Care Medicine.Read more
The European Renal Association - European Dialysis and Transplant organize the XLVIII ERA-EDTA Congress in Prague.Read more
Over 5000 delegates and Laboratory Medicine professionals are expected to attend the 21st International Congress of Clinical Chemistry and Laboratory Medicine.Read more
BioPorto Diagnostics wil attend the World Congress of Nephrology.Read more
BioPorto Diagnostics will be promoting The NGAL Test™ CE IVD for diagnostic use in Europe at the International Symposium on Intensive Care and Emergency Medicine, ISICEM.Read more
BioPorto Diagnostics will be exhibiting at the upcoming International17th Annual congress of the Indian Society of Critical Care Medicine (ISCCM) and International Critical Care Congress 2011.Read more
Dako Denmark A/S, Reagent Partnership Division, presented data and results of a validation study on The NGAL Test™ at the21st International Congress of Clinical Chemistry and Laboratory Medicine (IFCC-World Lab) in Berlin.Read more
BioPorto has CE-marked and is now launching The NGAL Test™ for diagnostic use in Europe.Read more
A new assay simply known as The NGAL Test makes it possible to get an earlydiagnosis of acute kidney injury.Read more
BioPorto Diagnostics is proud to announce a scientific poster presentation at the BRS/RA Conference in Manchester that includes data obtained with The NGAL Test...Read more
BioPorto Diagnostics announces the presentation of a new scientific study that includes data obtained with The NGAL Test - the company's forthcoming diagnostic test for acute kidney injury...Read more